Toma, H., Kelly, R., Katz, C., Hong, H., Diasti, H., Warshal, D. P., & Krill, L. Pembrolizumab and lenvatinib in the treatment of recurrent ovarian carcinoma: A single institution experience. Elsevier.
Chicago Style (17th ed.) CitationToma, Helen, Rebeca Kelly, Chelsea Katz, Hannah Hong, Hannah Diasti, David P. Warshal, and Lauren Krill. Pembrolizumab and Lenvatinib in the Treatment of Recurrent Ovarian Carcinoma: A Single Institution Experience. Elsevier.
MLA (9th ed.) CitationToma, Helen, et al. Pembrolizumab and Lenvatinib in the Treatment of Recurrent Ovarian Carcinoma: A Single Institution Experience. Elsevier.
Warning: These citations may not always be 100% accurate.